Palantir reported more than 50% growth in earnings from U.S. government contracts last quarter, boosted by the White House's push for cost-cutting and adoption of artificial-intelligence technology.

The benchmark Nifty-50 index could see a recovery in the short term. On the higher end, it might move towards 24850/25000.

Gold futures were retreating on rising risk-sentiment, though they remained higher on week. Futures were down 0.6% at $3,407.0 a troy ounce, though they remain up around 2.5% on week following ...

The report mentions that the three key investor segments of insiders, domestic households, and foreign institutional ...

RenaissanceRe's RNR.PR.G preferred stock offers high yields, 11% capital appreciation, and stable income. Read the full ...

India’s benchmark indices, the Sensex and Nifty, closed lower on Tuesday as investor sentiment weakened amid renewed tariff ...

AIG has been putting more emphasis on property and casualty insurance following the spinoff of its life insurance and ...

Palantir delivered a stellar Q2, beating expectations on revenue, EPS, and guidance, with accelerating growth and strong ...

Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...

Welcure Drugs & Pharmaceuticals' penny stock surged 660% over five years and 164% in two years. It hit a 5% upper circuit on August 5, 2025, following a strong Q1FY26 report showing a 1300% revenue ...

With U.S. stock markets set to open in two hours, BWX Technologies Inc. (BWXT) was up 13.7% in pre-market trading, and Madrigal Pharmaceuticals Inc. (MDGL) was up 11.5%.